| 0.3 |
0.9 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 0.3 |
1.1 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.3 |
0.5 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.2 |
1.7 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.2 |
1.9 |
GO:0060482 |
lobar bronchus development(GO:0060482) |
| 0.2 |
1.8 |
GO:0045959 |
regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.2 |
0.6 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.2 |
1.0 |
GO:0002415 |
immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.2 |
1.6 |
GO:1902998 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.2 |
0.2 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.2 |
0.5 |
GO:0002731 |
negative regulation of dendritic cell cytokine production(GO:0002731) |
| 0.2 |
0.6 |
GO:0032764 |
negative regulation of mast cell cytokine production(GO:0032764) |
| 0.2 |
0.5 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
| 0.1 |
1.0 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.1 |
0.9 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.1 |
0.6 |
GO:0042361 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.1 |
0.4 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.1 |
0.4 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.8 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.1 |
0.8 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 |
0.4 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.1 |
0.3 |
GO:0051795 |
positive regulation of catagen(GO:0051795) |
| 0.1 |
0.4 |
GO:0046603 |
negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.1 |
0.7 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.1 |
0.2 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.1 |
0.5 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 |
1.3 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.1 |
0.3 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 |
0.1 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.1 |
0.6 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.9 |
GO:0021842 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.1 |
0.1 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.1 |
0.3 |
GO:0032849 |
positive regulation of cellular pH reduction(GO:0032849) |
| 0.1 |
0.1 |
GO:0035965 |
cardiolipin metabolic process(GO:0032048) cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.1 |
0.5 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.1 |
0.3 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
0.4 |
GO:1903027 |
regulation of opsonization(GO:1903027) |
| 0.1 |
0.3 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.1 |
0.1 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.1 |
0.7 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.1 |
0.3 |
GO:0048597 |
B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.1 |
0.3 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.1 |
0.1 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 0.1 |
0.6 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
0.6 |
GO:1903281 |
positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.1 |
0.6 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
0.4 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.1 |
0.3 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.1 |
0.1 |
GO:0010771 |
negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
| 0.1 |
0.4 |
GO:0002399 |
MHC class II protein complex assembly(GO:0002399) |
| 0.1 |
1.1 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.4 |
GO:1902045 |
negative regulation of Fas signaling pathway(GO:1902045) |
| 0.1 |
0.6 |
GO:0009753 |
response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.1 |
0.4 |
GO:1905072 |
apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.1 |
0.4 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.1 |
0.4 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.1 |
0.3 |
GO:0098942 |
regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
| 0.1 |
0.4 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
0.5 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.1 |
0.8 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.1 |
0.3 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.1 |
0.3 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.1 |
0.3 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.1 |
0.2 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 |
0.4 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.1 |
0.2 |
GO:0002586 |
regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.1 |
0.3 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.1 |
0.2 |
GO:1902559 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.1 |
0.5 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.3 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.1 |
0.2 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.1 |
0.3 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.1 |
0.4 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.1 |
1.2 |
GO:0045836 |
positive regulation of meiotic nuclear division(GO:0045836) |
| 0.1 |
0.9 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
0.2 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.1 |
0.4 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.1 |
0.2 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.1 |
0.2 |
GO:1902996 |
regulation of neurofibrillary tangle assembly(GO:1902996) |
| 0.1 |
0.4 |
GO:0060356 |
leucine import(GO:0060356) |
| 0.1 |
0.1 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 |
0.1 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.1 |
0.2 |
GO:0098972 |
dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.1 |
0.4 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.1 |
0.2 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 |
0.7 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
0.4 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 0.1 |
0.1 |
GO:0003097 |
renal water transport(GO:0003097) renal water absorption(GO:0070295) |
| 0.1 |
0.2 |
GO:0043438 |
acetoacetic acid metabolic process(GO:0043438) |
| 0.1 |
0.1 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 |
0.3 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
0.1 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.1 |
0.5 |
GO:0002606 |
positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.1 |
0.1 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
0.2 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.1 |
0.1 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 0.1 |
0.3 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
0.2 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 |
0.2 |
GO:0019285 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.1 |
1.4 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.0 |
0.1 |
GO:2000724 |
nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
| 0.0 |
0.1 |
GO:0060981 |
cell migration involved in coronary angiogenesis(GO:0060981) |
| 0.0 |
0.2 |
GO:0019442 |
tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.0 |
0.1 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.0 |
0.2 |
GO:2000053 |
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.0 |
0.4 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.0 |
0.5 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.0 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.0 |
0.2 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 0.0 |
0.5 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.0 |
0.1 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.0 |
0.7 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.3 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.0 |
0.2 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.0 |
0.0 |
GO:0060746 |
maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.0 |
0.1 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.0 |
0.7 |
GO:0016102 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.0 |
0.0 |
GO:0021539 |
subthalamus development(GO:0021539) |
| 0.0 |
0.2 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.0 |
0.1 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.0 |
0.0 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.0 |
0.2 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.0 |
0.0 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.0 |
0.1 |
GO:0061075 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.0 |
0.3 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.0 |
0.5 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.0 |
0.2 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.0 |
0.1 |
GO:0001807 |
type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
| 0.0 |
0.1 |
GO:0052553 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.0 |
0.2 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.0 |
0.5 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.0 |
0.1 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.0 |
0.2 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.0 |
0.3 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.0 |
0.1 |
GO:0002372 |
myeloid dendritic cell cytokine production(GO:0002372) |
| 0.0 |
0.0 |
GO:2000866 |
positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.0 |
0.3 |
GO:1903788 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.0 |
0.3 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.0 |
0.2 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.0 |
0.6 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 |
0.2 |
GO:0072299 |
visceral serous pericardium development(GO:0061032) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.0 |
0.0 |
GO:0003220 |
left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
| 0.0 |
0.2 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.0 |
0.5 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.1 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.0 |
0.1 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.0 |
0.2 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.0 |
0.0 |
GO:0097324 |
melanocyte migration(GO:0097324) |
| 0.0 |
0.2 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.0 |
0.1 |
GO:0060750 |
epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
| 0.0 |
0.2 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.0 |
0.1 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.0 |
0.2 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.0 |
0.3 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.0 |
0.1 |
GO:0042668 |
auditory receptor cell fate determination(GO:0042668) |
| 0.0 |
0.2 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.0 |
0.3 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.0 |
0.0 |
GO:0060509 |
Type I pneumocyte differentiation(GO:0060509) |
| 0.0 |
0.1 |
GO:2000295 |
regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 0.0 |
0.1 |
GO:0052151 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.0 |
0.6 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.0 |
0.4 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.0 |
0.5 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 |
4.7 |
GO:0070268 |
cornification(GO:0070268) |
| 0.0 |
0.2 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.0 |
0.2 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.0 |
0.3 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.2 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.0 |
0.3 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 |
0.1 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.0 |
0.1 |
GO:0015827 |
tryptophan transport(GO:0015827) |
| 0.0 |
0.2 |
GO:0032730 |
positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.0 |
0.1 |
GO:0002368 |
B cell cytokine production(GO:0002368) |
| 0.0 |
0.2 |
GO:1902228 |
mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.0 |
0.1 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 |
0.1 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.0 |
0.0 |
GO:0015820 |
leucine transport(GO:0015820) |
| 0.0 |
0.1 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.0 |
0.1 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 |
0.3 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.0 |
0.1 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.0 |
0.1 |
GO:0009080 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.0 |
0.2 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.0 |
0.1 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.0 |
0.0 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.1 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.0 |
0.4 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.0 |
0.1 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.0 |
0.1 |
GO:1903762 |
regulation of heart looping(GO:1901207) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 0.0 |
0.3 |
GO:0007351 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 |
0.1 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.0 |
0.1 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) |
| 0.0 |
0.1 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.0 |
0.2 |
GO:0014718 |
positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.0 |
0.4 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 |
0.1 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.0 |
0.1 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.0 |
0.2 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.0 |
0.1 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.0 |
0.0 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.0 |
0.1 |
GO:1905075 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.0 |
0.2 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.0 |
0.0 |
GO:0060315 |
negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.0 |
0.3 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 |
0.6 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.0 |
0.2 |
GO:0042476 |
odontogenesis(GO:0042476) |
| 0.0 |
0.1 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.0 |
0.1 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.0 |
0.3 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.0 |
0.5 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.0 |
0.1 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.0 |
0.6 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.0 |
0.1 |
GO:2000338 |
chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
| 0.0 |
0.1 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.0 |
0.1 |
GO:0034371 |
chylomicron remodeling(GO:0034371) |
| 0.0 |
0.2 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.0 |
0.0 |
GO:0099545 |
trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
| 0.0 |
0.1 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.0 |
0.2 |
GO:0010751 |
regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.0 |
0.6 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.0 |
0.3 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.0 |
0.2 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.0 |
0.2 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.0 |
0.1 |
GO:0003131 |
mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) regulation of cellular response to X-ray(GO:2000683) positive regulation of cellular response to X-ray(GO:2000685) |
| 0.0 |
0.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.0 |
0.1 |
GO:0072071 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
| 0.0 |
0.1 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.0 |
0.3 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.0 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.0 |
0.1 |
GO:0014734 |
skeletal muscle hypertrophy(GO:0014734) |
| 0.0 |
0.1 |
GO:0033594 |
response to hydroxyisoflavone(GO:0033594) |
| 0.0 |
0.4 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 |
0.1 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.0 |
0.9 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.0 |
0.0 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.0 |
0.1 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.0 |
0.1 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.0 |
0.2 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.1 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.0 |
0.1 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.0 |
0.1 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.0 |
0.1 |
GO:0015853 |
adenine transport(GO:0015853) |
| 0.0 |
0.1 |
GO:0060809 |
mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.0 |
0.1 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.0 |
0.1 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.0 |
0.0 |
GO:0009395 |
phospholipid catabolic process(GO:0009395) |
| 0.0 |
0.1 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.0 |
0.2 |
GO:0030421 |
defecation(GO:0030421) |
| 0.0 |
0.2 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.0 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) oncogene-induced cell senescence(GO:0090402) |
| 0.0 |
0.2 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.0 |
0.1 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.0 |
0.2 |
GO:0072719 |
cellular response to cisplatin(GO:0072719) |
| 0.0 |
0.9 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.0 |
0.2 |
GO:0030320 |
cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 0.0 |
0.1 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.0 |
0.1 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 |
0.2 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.1 |
GO:0051466 |
positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.0 |
0.2 |
GO:0061441 |
renal artery morphogenesis(GO:0061441) |
| 0.0 |
0.1 |
GO:1901569 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.0 |
0.4 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 |
0.1 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.0 |
0.2 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.0 |
0.1 |
GO:0010212 |
response to ionizing radiation(GO:0010212) |
| 0.0 |
0.2 |
GO:0039663 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.0 |
0.9 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 |
0.0 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 |
0.1 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 0.0 |
0.1 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.0 |
0.3 |
GO:0070294 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.1 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 0.0 |
0.1 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.0 |
0.1 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) regulation of interleukin-1 alpha secretion(GO:0050705) |
| 0.0 |
0.1 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.0 |
0.0 |
GO:0051255 |
spindle midzone assembly(GO:0051255) |
| 0.0 |
0.1 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.0 |
0.1 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.0 |
0.1 |
GO:0050928 |
negative regulation of positive chemotaxis(GO:0050928) |
| 0.0 |
0.1 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
| 0.0 |
0.5 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.0 |
0.1 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.0 |
0.1 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.0 |
3.4 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.0 |
0.1 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.0 |
0.1 |
GO:0003404 |
optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) |
| 0.0 |
0.1 |
GO:0060154 |
cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.0 |
0.3 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 |
0.1 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.0 |
0.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.1 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.0 |
0.0 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 |
0.1 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.0 |
0.0 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.0 |
0.0 |
GO:1905123 |
regulation of glucosylceramidase activity(GO:1905123) |
| 0.0 |
0.0 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 |
0.0 |
GO:0010269 |
response to selenium ion(GO:0010269) |
| 0.0 |
0.2 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.0 |
0.1 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 |
0.4 |
GO:0051256 |
mitotic spindle midzone assembly(GO:0051256) |
| 0.0 |
0.1 |
GO:0001660 |
fever generation(GO:0001660) |
| 0.0 |
0.0 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.0 |
0.1 |
GO:0021586 |
pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.0 |
0.2 |
GO:0032057 |
negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 |
0.1 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.0 |
0.1 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.0 |
0.2 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.0 |
0.1 |
GO:0036111 |
very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.0 |
0.1 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 |
0.1 |
GO:0038112 |
interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.0 |
0.4 |
GO:0051450 |
myoblast proliferation(GO:0051450) |
| 0.0 |
0.1 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.0 |
0.2 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.0 |
0.1 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.0 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
0.0 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.0 |
0.0 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.0 |
0.1 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.0 |
0.0 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 0.0 |
0.7 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.1 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.0 |
0.4 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.0 |
0.0 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.2 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.0 |
0.0 |
GO:0048880 |
sensory system development(GO:0048880) |
| 0.0 |
0.1 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.0 |
0.0 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.0 |
0.1 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.0 |
0.1 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.0 |
0.1 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.0 |
0.1 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.0 |
0.1 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.0 |
0.1 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.0 |
0.1 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.0 |
0.1 |
GO:0038123 |
toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.0 |
0.1 |
GO:0010816 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.0 |
0.1 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.0 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 |
0.0 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.0 |
0.1 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 |
0.1 |
GO:0035105 |
sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.0 |
0.2 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.0 |
0.0 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.0 |
0.0 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.2 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.0 |
0.1 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.0 |
0.0 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.0 |
0.0 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.0 |
0.0 |
GO:0060761 |
negative regulation of response to cytokine stimulus(GO:0060761) |
| 0.0 |
0.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.1 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.0 |
0.1 |
GO:0042264 |
peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.0 |
0.1 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
| 0.0 |
0.3 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.0 |
0.2 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.1 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 |
0.0 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.1 |
GO:0016572 |
histone phosphorylation(GO:0016572) |
| 0.0 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.1 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
0.2 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.0 |
0.1 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 0.0 |
0.1 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.0 |
0.1 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.0 |
0.0 |
GO:0071613 |
granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 0.0 |
0.3 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.0 |
0.0 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.0 |
0.4 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.0 |
0.2 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.0 |
0.4 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
0.1 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.0 |
0.1 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.0 |
0.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.0 |
GO:2000468 |
regulation of peroxidase activity(GO:2000468) |
| 0.0 |
0.1 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.2 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.0 |
0.4 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 |
0.2 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 |
0.1 |
GO:0003160 |
endocardium morphogenesis(GO:0003160) |
| 0.0 |
0.0 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 0.0 |
0.1 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.0 |
0.1 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.0 |
0.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.1 |
GO:0010756 |
regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.1 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.0 |
0.1 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.0 |
0.2 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.0 |
0.1 |
GO:0061582 |
colon epithelial cell migration(GO:0061580) intestinal epithelial cell migration(GO:0061582) |
| 0.0 |
0.2 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.1 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.0 |
0.2 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.0 |
0.1 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.0 |
0.3 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.0 |
0.0 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 |
0.4 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.0 |
GO:0045799 |
positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 0.0 |
0.0 |
GO:0014717 |
regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.0 |
0.2 |
GO:0060546 |
negative regulation of necroptotic process(GO:0060546) |
| 0.0 |
0.2 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.0 |
0.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
0.1 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.0 |
0.0 |
GO:0060577 |
pulmonary vein morphogenesis(GO:0060577) |
| 0.0 |
0.1 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
0.2 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.0 |
0.0 |
GO:0060149 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.0 |
0.1 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.0 |
0.1 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
0.1 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.0 |
0.1 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 |
0.1 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.0 |
0.0 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.0 |
0.5 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.2 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.0 |
0.0 |
GO:0060523 |
prostate epithelial cord elongation(GO:0060523) |
| 0.0 |
0.1 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.1 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 0.0 |
0.1 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.0 |
0.3 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.2 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.2 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.0 |
0.4 |
GO:0032802 |
low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.0 |
0.0 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.0 |
0.0 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.0 |
0.0 |
GO:0034139 |
regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.0 |
0.2 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.0 |
0.1 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.0 |
0.0 |
GO:0036023 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.0 |
0.1 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.0 |
0.2 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.3 |
GO:0035589 |
G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.0 |
0.1 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.0 |
0.0 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 |
0.1 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.0 |
0.1 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.0 |
0.0 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.0 |
0.1 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 |
0.0 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
| 0.0 |
0.1 |
GO:0070197 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.0 |
0.0 |
GO:1904404 |
cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.0 |
0.3 |
GO:0043578 |
nuclear matrix organization(GO:0043578) |
| 0.0 |
0.0 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.0 |
0.0 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.0 |
0.2 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.0 |
0.0 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.0 |
0.0 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.0 |
0.1 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.0 |
0.0 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.0 |
0.0 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.0 |
0.2 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.0 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.0 |
0.3 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.1 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.0 |
0.4 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.0 |
GO:0010193 |
response to ozone(GO:0010193) |
| 0.0 |
0.0 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.0 |
0.2 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.1 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 0.0 |
0.1 |
GO:0060168 |
positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.0 |
0.1 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.0 |
0.0 |
GO:0051932 |
regulation of synaptic transmission, GABAergic(GO:0032228) synaptic transmission, GABAergic(GO:0051932) |
| 0.0 |
0.0 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.0 |
0.1 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.0 |
0.6 |
GO:0045840 |
positive regulation of mitotic nuclear division(GO:0045840) |
| 0.0 |
0.1 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.0 |
0.2 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.0 |
0.2 |
GO:1900116 |
extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 |
0.1 |
GO:0042247 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.0 |
0.0 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.0 |
0.1 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.0 |
0.1 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.0 |
0.1 |
GO:0070541 |
response to platinum ion(GO:0070541) |
| 0.0 |
0.1 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.0 |
0.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.0 |
0.1 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.0 |
0.2 |
GO:0032875 |
regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.0 |
0.1 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 |
0.2 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.0 |
0.1 |
GO:1900103 |
positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
| 0.0 |
0.2 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.0 |
0.4 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.0 |
0.1 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.0 |
0.2 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.0 |
0.1 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.0 |
0.0 |
GO:0043587 |
tongue morphogenesis(GO:0043587) fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) fungiform papilla formation(GO:0061198) |
| 0.0 |
0.1 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.0 |
0.0 |
GO:0035802 |
adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.0 |
0.0 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.0 |
0.2 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.0 |
GO:0043311 |
regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) regulation of eosinophil activation(GO:1902566) positive regulation of eosinophil activation(GO:1902568) |
| 0.0 |
0.4 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 |
0.1 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.0 |
0.0 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.0 |
0.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 |
0.0 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 |
0.6 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.0 |
0.1 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.0 |
0.0 |
GO:0006584 |
catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
| 0.0 |
0.1 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
| 0.0 |
0.2 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.0 |
0.3 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.0 |
0.1 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.0 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.0 |
0.0 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.0 |
0.1 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.0 |
0.0 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.0 |
0.0 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.0 |
0.1 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.0 |
0.1 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.0 |
0.1 |
GO:1902004 |
positive regulation of beta-amyloid formation(GO:1902004) |
| 0.0 |
0.1 |
GO:0019556 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 |
0.0 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
| 0.0 |
0.2 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.3 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.0 |
0.1 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
0.1 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.0 |
0.1 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.0 |
0.3 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.0 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.0 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.0 |
0.0 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.1 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.0 |
0.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.3 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.1 |
GO:1903797 |
positive regulation of inorganic anion transmembrane transport(GO:1903797) |
| 0.0 |
0.1 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.3 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.0 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.0 |
0.1 |
GO:0035729 |
cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.0 |
0.4 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.0 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.1 |
GO:0010734 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.0 |
0.1 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.0 |
0.1 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.0 |
0.0 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.0 |
0.1 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 |
0.2 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.0 |
0.2 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 |
0.1 |
GO:0006921 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
| 0.0 |
0.0 |
GO:0036071 |
N-glycan fucosylation(GO:0036071) |
| 0.0 |
0.1 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
0.2 |
GO:0046479 |
glycosphingolipid catabolic process(GO:0046479) ceramide catabolic process(GO:0046514) |
| 0.0 |
0.0 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.0 |
0.2 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.0 |
0.1 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.0 |
0.1 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.0 |
0.0 |
GO:1903321 |
negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
| 0.0 |
0.1 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.0 |
0.0 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.0 |
0.1 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.0 |
0.0 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.0 |
0.1 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.0 |
0.0 |
GO:0060005 |
vestibular reflex(GO:0060005) |
| 0.0 |
0.1 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
| 0.0 |
0.1 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) |
| 0.0 |
0.0 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 0.0 |
0.0 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.0 |
0.0 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.0 |
0.0 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 |
0.1 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.0 |
0.0 |
GO:0046602 |
mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) |
| 0.0 |
0.0 |
GO:0098917 |
retrograde trans-synaptic signaling(GO:0098917) |
| 0.0 |
0.1 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.0 |
0.0 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.0 |
0.1 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.1 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 |
0.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.2 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.2 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.0 |
0.1 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.0 |
0.0 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.0 |
0.1 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.0 |
0.0 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 |
0.4 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.0 |
0.0 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.0 |
0.0 |
GO:0030219 |
megakaryocyte differentiation(GO:0030219) |
| 0.0 |
0.1 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.0 |
0.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.0 |
GO:0034343 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.0 |
0.0 |
GO:0060544 |
regulation of necroptotic process(GO:0060544) |
| 0.0 |
0.3 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 |
0.0 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.0 |
0.0 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.0 |
0.4 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 |
0.1 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.0 |
0.0 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.0 |
0.1 |
GO:1904322 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 |
0.0 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) |
| 0.0 |
0.0 |
GO:0090025 |
regulation of monocyte chemotaxis(GO:0090025) |
| 0.0 |
0.0 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.0 |
0.1 |
GO:0090303 |
positive regulation of wound healing(GO:0090303) |
| 0.0 |
0.1 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.0 |
0.1 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.0 |
0.1 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
0.0 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.0 |
0.0 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.0 |
0.1 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.0 |
0.2 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.1 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.0 |
0.0 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.0 |
0.0 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.0 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.0 |
0.0 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.1 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
